» Articles » PMID: 29732012

Deciphering the Roles of LncRNAs in Breast Development and Disease

Overview
Journal Oncotarget
Specialty Oncology
Date 2018 May 8
PMID 29732012
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer is the second leading cause of cancer related deaths in women. It is therefore important to understand the mechanisms underlying breast cancer development as well as raises the need for enhanced, non-invasive strategies for novel prognostic and diagnostic methods. The emergence of long non-coding RNAs (lncRNAs) as potential key players in neoplastic disease has received considerable attention over the past few years. This relatively new class of molecular regulators has been shown from ongoing research to act as critical players for key biological processes. Deregulated expression levels of lncRNAs have been observed in a number of cancers including breast cancer. Furthermore, lncRNAs have been linked to breast cancer initiation, progression, metastases and to limit sensitivity to certain targeted therapeutics. In this review we provide an update on the lncRNAs associated with breast cancer and mammary gland development and illustrate the versatility of such lncRNAs in gene control, differentiation and development both in normal physiological conditions and in diseased states. We also highlight the therapeutic and diagnostic potential of lncRNAs in cancer.

Citing Articles

Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.

Hussain M, Sharma S, Kumari A, Kamran A, Bahl G, Bisht A Epigenomics. 2024; 16(23-24):1453-1464.

PMID: 39601046 PMC: 11622780. DOI: 10.1080/17501911.2024.2430170.


Induction of Invasive Basal Phenotype in Triple-Negative Breast Cancers by Long Noncoding RNA BORG.

Niazi F, Parker K, Mason S, Singh S, Schiemann W, Valadkhan S Cancers (Basel). 2024; 16(18).

PMID: 39335212 PMC: 11430157. DOI: 10.3390/cancers16183241.


The role of lncRNA NEAT1 in human cancer chemoresistance.

Long F, Li X, Pan J, Ye H, Di C, Huang Y Cancer Cell Int. 2024; 24(1):236.

PMID: 38970092 PMC: 11227196. DOI: 10.1186/s12935-024-03426-x.


Non-coding RNA regulates the immune microenvironment in recurrent spontaneous abortion (RSA): new insights into immune mechanisms†.

Tang C, Hu W Biol Reprod. 2023; 110(2):220-229.

PMID: 37956412 PMC: 10873270. DOI: 10.1093/biolre/ioad157.


Noncoding RNAs in atherosclerosis: regulation and therapeutic potential.

Qi L, Xing J, Yuan Y, Lei M Mol Cell Biochem. 2023; 479(5):1279-1295.

PMID: 37418054 PMC: 11116212. DOI: 10.1007/s11010-023-04794-0.


References
1.
Ke H, Zhao L, Feng X, Xu H, Zou L, Yang Q . NEAT1 is Required for Survival of Breast Cancer Cells Through FUS and miR-548. Gene Regul Syst Bio. 2016; 10(Suppl 1):11-7. PMC: 4849421. DOI: 10.4137/GRSB.S29414. View

2.
Sternlicht M . Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res. 2006; 8(1):201. PMC: 1413974. DOI: 10.1186/bcr1368. View

3.
Pageau G, Hall L, Lawrence J . BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. J Cell Biochem. 2006; 100(4):835-50. DOI: 10.1002/jcb.21188. View

4.
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z . LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013; 41(9):4976-87. PMC: 3643595. DOI: 10.1093/nar/gkt182. View

5.
Askarian-Amiri M, Crawford J, French J, Smart C, Smith M, Clark M . SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA. 2011; 17(5):878-91. PMC: 3078737. DOI: 10.1261/rna.2528811. View